Glucose-lowering Potential of Diabetes Therapies*
{"Image DocumentName": "Glucose-lowering Potential of Diabetes Therapies", "Image ImageDescription": "Treatment FPG \u00af HbA1C \u00af Sulfonylureas mg/dl 1-2% Metformin mg/dl 1-2% a-Glucosidase Inhibitors (Precose) mg/dl 0.5-1% Repaglinade (Prandin) 60mg/dl 1.7% Thiazolidinediones mg/dl 1-2% Gliptins (Januvia,Onglyza) targets ppd %  based on package insert data as monotherapy.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}